Period:
Draw Mode:
| Volume | 32,526 |
|
|||||
| News | - | ||||||
| Day High | 0.68 | Low High |
|||||
| Day Low | 0.66 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Nighthawk Biosciences Inc | NHWK | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0098 | 1.46% | 0.6798 | 16:20:23 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.67 | 0.66 | 0.68 | 0.6798 | 0.67 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 241 | 32,526 | $ 0.6693376 | $ 21,771 | - | 0.65 - 3.42 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:32:31 | 20 | $ 0.686 | USD |
Nighthawk Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 17.71M | 26.05M | 24.71M | $ 765.90k | $ -128.98k | -0.49 | -137.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 9.90% |
Nighthawk Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NHWK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.7286 | 0.736799 | 0.65 | 0.682107 | 52,871 | -0.0488 | -6.7% |
| 1 Month | 0.73 | 0.799799 | 0.65 | 0.7245295 | 46,861 | -0.0502 | -6.88% |
| 3 Months | 0.93 | 0.96 | 0.65 | 0.774623 | 43,524 | -0.2502 | -26.9% |
| 6 Months | 1.19 | 1.30 | 0.65 | 0.9207312 | 55,359 | -0.5102 | -42.87% |
| 1 Year | 2.34 | 3.42 | 0.65 | 2.04 | 123,241 | -1.66 | -70.95% |
| 3 Years | 2.50 | 3.42 | 0.65 | 2.05 | 120,159 | -1.82 | -72.81% |
| 5 Years | 2.50 | 3.42 | 0.65 | 2.05 | 120,159 | -1.82 | -72.81% |
Nighthawk Biosciences Description
| Heat Biologics, Inc. is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Heat Biologics, Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Heat Biologics, Inc.. Heat Biologics Inc is a US-based immuno-oncology company. It is engaged in developing therapies that activate a patient's immune system against cancer utilizing an engineered form of gp96. The group's T cell-stimulating therapeutic vaccine platform technologies, Immune Pan-Antigen Cytotoxic Therapy (ImPACT) and Combination Pan-Antigen Cytotoxic Therapy (ComPACT), form the basis of its product candidates. |